nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—Gefitinib—CHEK2—ovarian cancer	0.0751	0.657	CrCbGaD
Minaprine—HTR2A—vein—ovarian cancer	0.0655	0.134	CbGeAlD
Minaprine—Gefitinib—EGFR—ovarian cancer	0.03	0.263	CrCbGaD
Minaprine—HTR2B—myometrium—ovarian cancer	0.0241	0.0493	CbGeAlD
Minaprine—MAOA—myometrium—ovarian cancer	0.0198	0.0403	CbGeAlD
Minaprine—MAOA—embryo—ovarian cancer	0.019	0.0388	CbGeAlD
Minaprine—HTR2B—uterine cervix—ovarian cancer	0.0188	0.0384	CbGeAlD
Minaprine—HTR2B—decidua—ovarian cancer	0.0179	0.0365	CbGeAlD
Minaprine—HTR2B—endometrium—ovarian cancer	0.017	0.0347	CbGeAlD
Minaprine—ACHE—testis—ovarian cancer	0.017	0.0346	CbGeAlD
Minaprine—HTR2B—uterus—ovarian cancer	0.0157	0.032	CbGeAlD
Minaprine—MAOA—uterine cervix—ovarian cancer	0.0154	0.0314	CbGeAlD
Minaprine—HTR2C—female reproductive system—ovarian cancer	0.015	0.0306	CbGeAlD
Minaprine—MAOA—decidua—ovarian cancer	0.0146	0.0299	CbGeAlD
Minaprine—SLC6A4—female reproductive system—ovarian cancer	0.0142	0.029	CbGeAlD
Minaprine—CHRM1—female reproductive system—ovarian cancer	0.0141	0.0289	CbGeAlD
Minaprine—HTR2B—female reproductive system—ovarian cancer	0.0141	0.0287	CbGeAlD
Minaprine—MAOA—endometrium—ovarian cancer	0.0139	0.0284	CbGeAlD
Minaprine—MAOA—uterus—ovarian cancer	0.0128	0.0262	CbGeAlD
Minaprine—HTR2B—vagina—ovarian cancer	0.0127	0.026	CbGeAlD
Minaprine—HTR2A—embryo—ovarian cancer	0.0124	0.0253	CbGeAlD
Minaprine—ACHE—lymph node—ovarian cancer	0.0123	0.0251	CbGeAlD
Minaprine—MAOA—female reproductive system—ovarian cancer	0.0115	0.0235	CbGeAlD
Minaprine—MAOA—female gonad—ovarian cancer	0.0105	0.0214	CbGeAlD
Minaprine—MAOA—vagina—ovarian cancer	0.0104	0.0213	CbGeAlD
Minaprine—HTR2A—epithelium—ovarian cancer	0.0101	0.0207	CbGeAlD
Minaprine—MAOA—testis—ovarian cancer	0.00929	0.019	CbGeAlD
Minaprine—DRD2—testis—ovarian cancer	0.00919	0.0188	CbGeAlD
Minaprine—Gefitinib—ABCB1—ovarian cancer	0.00912	0.0799	CrCbGaD
Minaprine—HTR2A—gonad—ovarian cancer	0.00841	0.0172	CbGeAlD
Minaprine—HTR2B—lymph node—ovarian cancer	0.00823	0.0168	CbGeAlD
Minaprine—HTR2A—female reproductive system—ovarian cancer	0.00751	0.0153	CbGeAlD
Minaprine—CYP2D6—female reproductive system—ovarian cancer	0.00684	0.014	CbGeAlD
Minaprine—HTR2A—vagina—ovarian cancer	0.0068	0.0139	CbGeAlD
Minaprine—MAOA—lymph node—ovarian cancer	0.00674	0.0138	CbGeAlD
Minaprine—CYP2D6—female gonad—ovarian cancer	0.00623	0.0127	CbGeAlD
Minaprine—HTR2A—testis—ovarian cancer	0.00606	0.0124	CbGeAlD
Minaprine—CYP2D6—testis—ovarian cancer	0.00552	0.0113	CbGeAlD
Minaprine—HTR2B—Signaling by GPCR—KRAS—ovarian cancer	0.000113	0.000285	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—MAPK1—ovarian cancer	0.000113	0.000284	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—EGFR—ovarian cancer	0.000113	0.000284	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ESR1—ovarian cancer	0.000112	0.000282	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL2—ovarian cancer	0.000111	0.000281	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TERT—ovarian cancer	0.000111	0.00028	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6ST—ovarian cancer	0.00011	0.000278	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	0.00011	0.000277	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL2—ovarian cancer	0.000109	0.000276	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TERT—ovarian cancer	0.000109	0.000275	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL2—ovarian cancer	0.000109	0.000275	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CD—ovarian cancer	0.000109	0.000274	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TERT—ovarian cancer	0.000108	0.000274	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000108	0.000272	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—KRAS—ovarian cancer	0.000106	0.000268	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APC—ovarian cancer	0.000106	0.000267	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CG—ovarian cancer	0.000106	0.000267	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—NRAS—ovarian cancer	0.000106	0.000267	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTEN—ovarian cancer	0.000105	0.000265	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—PIK3CA—ovarian cancer	0.000104	0.000262	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CAV1—ovarian cancer	0.000102	0.000259	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ERBB2—ovarian cancer	0.000102	0.000257	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—MAPK3—ovarian cancer	0.000101	0.000256	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CAV1—ovarian cancer	0.000101	0.000254	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MTOR—ovarian cancer	0.0001	0.000253	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CB—ovarian cancer	0.0001	0.000253	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CAV1—ovarian cancer	0.0001	0.000253	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTEN—ovarian cancer	9.9e-05	0.00025	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ESR1—ovarian cancer	9.87e-05	0.000249	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—PIK3CA—ovarian cancer	9.77e-05	0.000247	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	9.73e-05	0.000245	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ESR1—ovarian cancer	9.71e-05	0.000245	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6ST—ovarian cancer	9.71e-05	0.000245	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ESR1—ovarian cancer	9.66e-05	0.000244	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CXCL8—ovarian cancer	9.65e-05	0.000244	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—MAPK1—ovarian cancer	9.63e-05	0.000243	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EGFR—ovarian cancer	9.63e-05	0.000243	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ERBB2—ovarian cancer	9.6e-05	0.000242	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HRAS—ovarian cancer	9.59e-05	0.000242	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6ST—ovarian cancer	9.56e-05	0.000241	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6ST—ovarian cancer	9.5e-05	0.00024	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CB—ovarian cancer	9.47e-05	0.000239	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MTOR—ovarian cancer	9.47e-05	0.000239	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CDKN1B—ovarian cancer	9.42e-05	0.000238	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CG—ovarian cancer	9.33e-05	0.000236	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APC—ovarian cancer	9.33e-05	0.000236	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—NRAS—ovarian cancer	9.33e-05	0.000235	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—ovarian cancer	9.32e-05	0.000235	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CD—ovarian cancer	9.29e-05	0.000235	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP3—ovarian cancer	9.24e-05	0.000233	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL2—ovarian cancer	9.22e-05	0.000233	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—PIK3CA—ovarian cancer	9.21e-05	0.000232	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CG—ovarian cancer	9.18e-05	0.000232	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APC—ovarian cancer	9.18e-05	0.000232	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—NRAS—ovarian cancer	9.18e-05	0.000232	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—ovarian cancer	9.18e-05	0.000232	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CG—ovarian cancer	9.13e-05	0.00023	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APC—ovarian cancer	9.13e-05	0.00023	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—NRAS—ovarian cancer	9.13e-05	0.00023	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL8—ovarian cancer	9.1e-05	0.00023	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—KRAS—ovarian cancer	9.1e-05	0.00023	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HRAS—ovarian cancer	9.04e-05	0.000228	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ABCB1—ovarian cancer	9.03e-05	0.000228	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCND1—ovarian cancer	8.99e-05	0.000227	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MAPK3—ovarian cancer	8.94e-05	0.000226	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CTNNB1—ovarian cancer	8.9e-05	0.000225	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CDKN1B—ovarian cancer	8.89e-05	0.000224	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TYMS—ovarian cancer	8.87e-05	0.000224	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MAPK3—ovarian cancer	8.79e-05	0.000222	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—ovarian cancer	8.79e-05	0.000222	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MAPK3—ovarian cancer	8.75e-05	0.000221	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—ovarian cancer	8.73e-05	0.00022	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—ovarian cancer	8.71e-05	0.00022	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL2—ovarian cancer	8.7e-05	0.000219	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTEN—ovarian cancer	8.68e-05	0.000219	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—ovarian cancer	8.65e-05	0.000218	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—MAPK1—ovarian cancer	8.5e-05	0.000215	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—ovarian cancer	8.5e-05	0.000215	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCND1—ovarian cancer	8.48e-05	0.000214	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—ovarian cancer	8.47e-05	0.000214	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CTNNB1—ovarian cancer	8.4e-05	0.000212	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—MAPK1—ovarian cancer	8.37e-05	0.000211	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—ovarian cancer	8.36e-05	0.000211	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PIK3CA—ovarian cancer	8.36e-05	0.000211	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—MAPK1—ovarian cancer	8.32e-05	0.00021	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—ovarian cancer	8.32e-05	0.00021	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—ovarian cancer	8.23e-05	0.000208	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ERBB2—ovarian cancer	8.21e-05	0.000207	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CD—ovarian cancer	8.2e-05	0.000207	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTEN—ovarian cancer	8.18e-05	0.000207	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—PIK3CA—ovarian cancer	8.12e-05	0.000205	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CB—ovarian cancer	8.1e-05	0.000204	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MTOR—ovarian cancer	8.1e-05	0.000204	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CD—ovarian cancer	8.07e-05	0.000204	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—KRAS—ovarian cancer	8.03e-05	0.000203	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CD—ovarian cancer	8.03e-05	0.000203	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—PIK3CA—ovarian cancer	7.99e-05	0.000202	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—ovarian cancer	7.98e-05	0.000201	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	7.95e-05	0.000201	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—KRAS—ovarian cancer	7.9e-05	0.000199	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—KRAS—ovarian cancer	7.86e-05	0.000198	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—ovarian cancer	7.84e-05	0.000198	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL8—ovarian cancer	7.79e-05	0.000196	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT3—ovarian cancer	7.76e-05	0.000196	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NRAS—ovarian cancer	7.74e-05	0.000195	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HRAS—ovarian cancer	7.73e-05	0.000195	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CDKN1B—ovarian cancer	7.6e-05	0.000192	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—ovarian cancer	7.52e-05	0.00019	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—ovarian cancer	7.45e-05	0.000188	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL2—ovarian cancer	7.44e-05	0.000188	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK3—ovarian cancer	7.41e-05	0.000187	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3CA—ovarian cancer	7.41e-05	0.000187	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—ovarian cancer	7.4e-05	0.000187	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—ovarian cancer	7.39e-05	0.000187	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PIK3CA—ovarian cancer	7.38e-05	0.000186	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT3—ovarian cancer	7.32e-05	0.000185	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NRAS—ovarian cancer	7.3e-05	0.000184	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CA—ovarian cancer	7.26e-05	0.000183	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCND1—ovarian cancer	7.25e-05	0.000183	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ERBB2—ovarian cancer	7.25e-05	0.000183	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CA—ovarian cancer	7.22e-05	0.000182	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MYC—ovarian cancer	7.21e-05	0.000182	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CTNNB1—ovarian cancer	7.18e-05	0.000181	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MTOR—ovarian cancer	7.15e-05	0.00018	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CB—ovarian cancer	7.15e-05	0.00018	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAV1—ovarian cancer	7.15e-05	0.00018	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ERBB2—ovarian cancer	7.13e-05	0.00018	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ERBB2—ovarian cancer	7.09e-05	0.000179	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MAPK1—ovarian cancer	7.05e-05	0.000178	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—ovarian cancer	7.05e-05	0.000178	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—ovarian cancer	7.04e-05	0.000178	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MTOR—ovarian cancer	7.04e-05	0.000178	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CB—ovarian cancer	7.04e-05	0.000178	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTEN—ovarian cancer	7e-05	0.000177	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CB—ovarian cancer	7e-05	0.000177	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MTOR—ovarian cancer	7e-05	0.000177	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK3—ovarian cancer	6.99e-05	0.000176	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CA—ovarian cancer	6.98e-05	0.000176	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL8—ovarian cancer	6.87e-05	0.000173	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—ovarian cancer	6.83e-05	0.000172	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HRAS—ovarian cancer	6.83e-05	0.000172	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MYC—ovarian cancer	6.8e-05	0.000172	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	6.76e-05	0.000171	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL8—ovarian cancer	6.72e-05	0.00017	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	6.72e-05	0.00017	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	6.71e-05	0.000169	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HRAS—ovarian cancer	6.68e-05	0.000169	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KRAS—ovarian cancer	6.66e-05	0.000168	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MAPK1—ovarian cancer	6.65e-05	0.000168	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—ovarian cancer	6.65e-05	0.000168	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	6.64e-05	0.000168	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	6.6e-05	0.000167	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—ovarian cancer	6.58e-05	0.000166	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CDKN1B—ovarian cancer	6.57e-05	0.000166	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL2—ovarian cancer	6.57e-05	0.000166	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—ovarian cancer	6.53e-05	0.000165	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	6.53e-05	0.000165	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	6.51e-05	0.000164	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—ovarian cancer	6.5e-05	0.000164	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—ovarian cancer	6.47e-05	0.000163	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL2—ovarian cancer	6.46e-05	0.000163	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—ovarian cancer	6.44e-05	0.000162	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—ovarian cancer	6.43e-05	0.000162	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL2—ovarian cancer	6.43e-05	0.000162	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCND1—ovarian cancer	6.4e-05	0.000162	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—ovarian cancer	6.39e-05	0.000161	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	6.34e-05	0.00016	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—ovarian cancer	6.32e-05	0.00016	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCND1—ovarian cancer	6.3e-05	0.000159	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KRAS—ovarian cancer	6.28e-05	0.000159	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCND1—ovarian cancer	6.26e-05	0.000158	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT3—ovarian cancer	6.26e-05	0.000158	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NRAS—ovarian cancer	6.25e-05	0.000158	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	6.24e-05	0.000157	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—ovarian cancer	6.21e-05	0.000157	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CTNNB1—ovarian cancer	6.2e-05	0.000157	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTEN—ovarian cancer	6.18e-05	0.000156	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CA—ovarian cancer	6.12e-05	0.000154	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—ovarian cancer	6.11e-05	0.000154	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—ovarian cancer	6.08e-05	0.000154	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTEN—ovarian cancer	6.08e-05	0.000153	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—ovarian cancer	6.06e-05	0.000153	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTEN—ovarian cancer	6.05e-05	0.000153	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	6.03e-05	0.000152	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	5.98e-05	0.000151	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	5.93e-05	0.00015	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—ovarian cancer	5.92e-05	0.000149	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	5.9e-05	0.000149	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MYC—ovarian cancer	5.82e-05	0.000147	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	5.77e-05	0.000146	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	5.72e-05	0.000144	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—ovarian cancer	5.71e-05	0.000144	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	5.69e-05	0.000144	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	5.69e-05	0.000144	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HRAS—ovarian cancer	5.66e-05	0.000143	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—ovarian cancer	5.58e-05	0.000141	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	5.58e-05	0.000141	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT3—ovarian cancer	5.53e-05	0.000139	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NRAS—ovarian cancer	5.51e-05	0.000139	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	5.49e-05	0.000139	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	5.46e-05	0.000138	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	5.44e-05	0.000137	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	5.42e-05	0.000137	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—ovarian cancer	5.42e-05	0.000137	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	5.41e-05	0.000136	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	5.39e-05	0.000136	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	5.38e-05	0.000136	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HRAS—ovarian cancer	5.34e-05	0.000135	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	5.28e-05	0.000133	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	5.19e-05	0.000131	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	5.17e-05	0.00013	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MYC—ovarian cancer	5.13e-05	0.00013	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—ovarian cancer	5.11e-05	0.000129	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MYC—ovarian cancer	5.05e-05	0.000128	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MYC—ovarian cancer	5.02e-05	0.000127	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	5.02e-05	0.000127	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—ovarian cancer	5.02e-05	0.000127	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—ovarian cancer	5e-05	0.000126	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.99e-05	0.000126	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	4.94e-05	0.000125	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	4.94e-05	0.000125	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	4.94e-05	0.000125	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	4.92e-05	0.000124	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	4.91e-05	0.000124	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—ovarian cancer	4.78e-05	0.000121	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KRAS—ovarian cancer	4.74e-05	0.00012	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—ovarian cancer	4.72e-05	0.000119	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	4.67e-05	0.000118	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	4.64e-05	0.000117	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	4.57e-05	0.000115	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—ovarian cancer	4.37e-05	0.00011	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	4.36e-05	0.00011	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTEN—ovarian cancer	4.31e-05	0.000109	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	4.29e-05	0.000108	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	4.27e-05	0.000108	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—ovarian cancer	4.22e-05	0.000106	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—ovarian cancer	4.15e-05	0.000105	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—ovarian cancer	4.13e-05	0.000104	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	4.03e-05	0.000102	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HRAS—ovarian cancer	4.03e-05	0.000102	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	3.97e-05	0.0001	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	3.95e-05	9.96e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—ovarian cancer	3.86e-05	9.74e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—ovarian cancer	3.8e-05	9.58e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—ovarian cancer	3.78e-05	9.53e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—ovarian cancer	3.56e-05	8.99e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	3.5e-05	8.84e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	3.48e-05	8.79e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	3.04e-05	7.67e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—ovarian cancer	2.48e-05	6.27e-05	CbGpPWpGaD
